Anti-inflammatory pharmacology and mechanism of the orally active capsaicin analogs, NE-19550 and NE-28345

L. M. Brand, K. L. Skare, M. E. Loomans, H. H. Reller, R. J. Schwen, D. A. Lade, R. L. Bohne, C. S. Maddin, D. P. Moorehead, R. Fanelli, C. Chiabrando, M. G. Castelli, H. H. Tai

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

We have evaluated the properties of a new class of anti-inflammatory agents derived from capsaicin, using the analogs NE-19550 (N-vanillyloleamide) and NE-28345 (N-oleyl-homovanillamide) as examples. This class displayed an atypical profile in the assays utilized, including 1) anti-edema and antileukocyte migration activity in the rat carrageenan pleurisy assay without suppression of pleural prostanoid synthesis, 2) blockade of human platelet aggregation induced by arachidonate or PAF but not that induced by the PGH2 analog U-46619, without equivalent inhibition in vitro of mammalian cyclooxygenase or thromboxane synthetase preparations, 3) greater potency and efficacy in the rat implanted sponge assay than in the adjuvant arthritis assay, without inhibition of LTB4 or 15-HETE synthesis in vitro, 4) stronger topical activity in the mouse croton oil inflamed ear assay than the guinea pig UV erythema assay, and 5) oral activity in the rat carrageenan paw edema assay and mouse phenylquinone abdominal constriction rest combined with failure to induce gastric erosion in rats at therapeutic doses. We conclude that NE-19550 and NE-28345 do not act like conventional NSAIDs via suppression of arachidonic acid metabolism.

Original languageEnglish
Pages (from-to)329-340
Number of pages12
JournalAgents and Actions
Volume31
Issue number3-4
DOIs
Publication statusPublished - Nov 1990

Fingerprint

Capsaicin
Assays
Anti-Inflammatory Agents
Pharmacology
Carrageenan
Rats
Edema
Croton Oil
Thromboxane-A Synthase
Prostaglandin H2
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
Pleurisy
Experimental Arthritis
Leukotriene B4
Porifera
Non-Steroidal Anti-Inflammatory Agents
Erythema
Prostaglandin-Endoperoxide Synthases
Platelet Aggregation
Arachidonic Acid

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology (medical)

Cite this

Brand, L. M., Skare, K. L., Loomans, M. E., Reller, H. H., Schwen, R. J., Lade, D. A., ... Tai, H. H. (1990). Anti-inflammatory pharmacology and mechanism of the orally active capsaicin analogs, NE-19550 and NE-28345. Agents and Actions, 31(3-4), 329-340. https://doi.org/10.1007/BF01997628

Anti-inflammatory pharmacology and mechanism of the orally active capsaicin analogs, NE-19550 and NE-28345. / Brand, L. M.; Skare, K. L.; Loomans, M. E.; Reller, H. H.; Schwen, R. J.; Lade, D. A.; Bohne, R. L.; Maddin, C. S.; Moorehead, D. P.; Fanelli, R.; Chiabrando, C.; Castelli, M. G.; Tai, H. H.

In: Agents and Actions, Vol. 31, No. 3-4, 11.1990, p. 329-340.

Research output: Contribution to journalArticle

Brand, LM, Skare, KL, Loomans, ME, Reller, HH, Schwen, RJ, Lade, DA, Bohne, RL, Maddin, CS, Moorehead, DP, Fanelli, R, Chiabrando, C, Castelli, MG & Tai, HH 1990, 'Anti-inflammatory pharmacology and mechanism of the orally active capsaicin analogs, NE-19550 and NE-28345', Agents and Actions, vol. 31, no. 3-4, pp. 329-340. https://doi.org/10.1007/BF01997628
Brand, L. M. ; Skare, K. L. ; Loomans, M. E. ; Reller, H. H. ; Schwen, R. J. ; Lade, D. A. ; Bohne, R. L. ; Maddin, C. S. ; Moorehead, D. P. ; Fanelli, R. ; Chiabrando, C. ; Castelli, M. G. ; Tai, H. H. / Anti-inflammatory pharmacology and mechanism of the orally active capsaicin analogs, NE-19550 and NE-28345. In: Agents and Actions. 1990 ; Vol. 31, No. 3-4. pp. 329-340.
@article{e94961a78e444c308b5278e8ee7a8d2e,
title = "Anti-inflammatory pharmacology and mechanism of the orally active capsaicin analogs, NE-19550 and NE-28345",
abstract = "We have evaluated the properties of a new class of anti-inflammatory agents derived from capsaicin, using the analogs NE-19550 (N-vanillyloleamide) and NE-28345 (N-oleyl-homovanillamide) as examples. This class displayed an atypical profile in the assays utilized, including 1) anti-edema and antileukocyte migration activity in the rat carrageenan pleurisy assay without suppression of pleural prostanoid synthesis, 2) blockade of human platelet aggregation induced by arachidonate or PAF but not that induced by the PGH2 analog U-46619, without equivalent inhibition in vitro of mammalian cyclooxygenase or thromboxane synthetase preparations, 3) greater potency and efficacy in the rat implanted sponge assay than in the adjuvant arthritis assay, without inhibition of LTB4 or 15-HETE synthesis in vitro, 4) stronger topical activity in the mouse croton oil inflamed ear assay than the guinea pig UV erythema assay, and 5) oral activity in the rat carrageenan paw edema assay and mouse phenylquinone abdominal constriction rest combined with failure to induce gastric erosion in rats at therapeutic doses. We conclude that NE-19550 and NE-28345 do not act like conventional NSAIDs via suppression of arachidonic acid metabolism.",
author = "Brand, {L. M.} and Skare, {K. L.} and Loomans, {M. E.} and Reller, {H. H.} and Schwen, {R. J.} and Lade, {D. A.} and Bohne, {R. L.} and Maddin, {C. S.} and Moorehead, {D. P.} and R. Fanelli and C. Chiabrando and Castelli, {M. G.} and Tai, {H. H.}",
year = "1990",
month = "11",
doi = "10.1007/BF01997628",
language = "English",
volume = "31",
pages = "329--340",
journal = "Inflammation Research",
issn = "1023-3830",
publisher = "Birkhauser Verlag Basel",
number = "3-4",

}

TY - JOUR

T1 - Anti-inflammatory pharmacology and mechanism of the orally active capsaicin analogs, NE-19550 and NE-28345

AU - Brand, L. M.

AU - Skare, K. L.

AU - Loomans, M. E.

AU - Reller, H. H.

AU - Schwen, R. J.

AU - Lade, D. A.

AU - Bohne, R. L.

AU - Maddin, C. S.

AU - Moorehead, D. P.

AU - Fanelli, R.

AU - Chiabrando, C.

AU - Castelli, M. G.

AU - Tai, H. H.

PY - 1990/11

Y1 - 1990/11

N2 - We have evaluated the properties of a new class of anti-inflammatory agents derived from capsaicin, using the analogs NE-19550 (N-vanillyloleamide) and NE-28345 (N-oleyl-homovanillamide) as examples. This class displayed an atypical profile in the assays utilized, including 1) anti-edema and antileukocyte migration activity in the rat carrageenan pleurisy assay without suppression of pleural prostanoid synthesis, 2) blockade of human platelet aggregation induced by arachidonate or PAF but not that induced by the PGH2 analog U-46619, without equivalent inhibition in vitro of mammalian cyclooxygenase or thromboxane synthetase preparations, 3) greater potency and efficacy in the rat implanted sponge assay than in the adjuvant arthritis assay, without inhibition of LTB4 or 15-HETE synthesis in vitro, 4) stronger topical activity in the mouse croton oil inflamed ear assay than the guinea pig UV erythema assay, and 5) oral activity in the rat carrageenan paw edema assay and mouse phenylquinone abdominal constriction rest combined with failure to induce gastric erosion in rats at therapeutic doses. We conclude that NE-19550 and NE-28345 do not act like conventional NSAIDs via suppression of arachidonic acid metabolism.

AB - We have evaluated the properties of a new class of anti-inflammatory agents derived from capsaicin, using the analogs NE-19550 (N-vanillyloleamide) and NE-28345 (N-oleyl-homovanillamide) as examples. This class displayed an atypical profile in the assays utilized, including 1) anti-edema and antileukocyte migration activity in the rat carrageenan pleurisy assay without suppression of pleural prostanoid synthesis, 2) blockade of human platelet aggregation induced by arachidonate or PAF but not that induced by the PGH2 analog U-46619, without equivalent inhibition in vitro of mammalian cyclooxygenase or thromboxane synthetase preparations, 3) greater potency and efficacy in the rat implanted sponge assay than in the adjuvant arthritis assay, without inhibition of LTB4 or 15-HETE synthesis in vitro, 4) stronger topical activity in the mouse croton oil inflamed ear assay than the guinea pig UV erythema assay, and 5) oral activity in the rat carrageenan paw edema assay and mouse phenylquinone abdominal constriction rest combined with failure to induce gastric erosion in rats at therapeutic doses. We conclude that NE-19550 and NE-28345 do not act like conventional NSAIDs via suppression of arachidonic acid metabolism.

UR - http://www.scopus.com/inward/record.url?scp=0025200440&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025200440&partnerID=8YFLogxK

U2 - 10.1007/BF01997628

DO - 10.1007/BF01997628

M3 - Article

VL - 31

SP - 329

EP - 340

JO - Inflammation Research

JF - Inflammation Research

SN - 1023-3830

IS - 3-4

ER -